Matsuyuki Shirota
Overview
Explore the profile of Matsuyuki Shirota including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
66
Citations
961
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bekker G, Nagao C, Shirota M, Nakamura T, Katayama T, Kihara D, et al.
Protein Sci
. 2025 Feb;
34(3):e70052.
PMID: 39969112
Protein Data Bank Japan (PDBj) is the Asian hub of three-dimensional macromolecular structure data, and a founding member of the worldwide Protein Data Bank. We have accepted, processed, and distributed...
2.
Yamamoto M, Ohtake S, Shinozawa A, Shirota M, Mitsui Y, Kitashiba H
New Phytol
. 2024 Sep;
244(4):1644-1657.
PMID: 39279039
Only very limited information is available on why some nonsynonymous variants severely alter gene function while others have no effect. To identify the characteristic features of mutations that strongly influence...
3.
Inamori K, Nakamura K, Shishido F, Hsu J, Nagafuku M, Nitta T, et al.
Front Neurosci
. 2024 Aug;
18:1437668.
PMID: 39145292
Hereditary spastic paraplegia (HSP) is a heterogeneous group of neurological disorders that are characterized by progressive spasticity and weakness in the lower limbs. SPG26 is a complicated form of HSP,...
4.
Yamamoto M, Ohtake S, Shinosawa A, Shirota M, Mitsui Y, Kitashiba H
bioRxiv
. 2024 Apr;
PMID: 38645205
Only very limited information is available on why some non-synonymous variants severely alter gene function while others have no effect. To identify the characteristic features of mutations that strongly influence...
5.
Noda A, Obara T, Shirota M, Ueno F, Matsuzaki F, Hatanaka R, et al.
Eur J Clin Pharmacol
. 2024 Apr;
80(8):1171-1180.
PMID: 38630193
Purpose: To elucidate the status of medication use among pregnant women in Japan, by means of a multigenerational genome and birth cohort study: the Tohoku Medical Megabank Project Birth and...
6.
Izumi R, Ikeda K, Niihori T, Suzuki N, Shirota M, Funayama R, et al.
Ann Clin Transl Neurol
. 2023 Dec;
11(3):577-592.
PMID: 38158701
Objective: Multisystem proteinopathy type 3 (MSP3) is an inherited, pleiotropic degenerative disorder caused by a mutation in heterogeneous nuclear ribonucleoprotein A1 (hnRNPA1), which can affect the muscle, bone, and/or nervous...
7.
Tadaka S, Kawashima J, Hishinuma E, Saito S, Okamura Y, Otsuki A, et al.
Nucleic Acids Res
. 2023 Nov;
52(D1):D622-D632.
PMID: 37930845
Modern medicine is increasingly focused on personalized medicine, and multi-omics data is crucial in understanding biological phenomena and disease mechanisms. Each ethnic group has its unique genetic background with specific...
8.
Fang Z, Li X, Yoshino Y, Suzuki M, Qi H, Murooka H, et al.
Cell Rep
. 2023 Jul;
42(8):112850.
PMID: 37481721
The BRCA1-interacting protein Obg-like ATPase 1 (OLA1) functions in centriole duplication. In this study, we show the role of the mitotic kinase Aurora A in the reduction of centrosomal OLA1....
9.
Okubo Y, Shibuya M, Nakamura H, Kawashima A, Kodama K, Endo W, et al.
Brain Dev
. 2023 Jul;
45(9):505-511.
PMID: 37442734
Variants of SCN1A represent the archetypal channelopathy associated with several epilepsy syndromes. The clinical phenotypes have recently expanded from Dravet syndrome. CASE REPORT: We present a female patient with the...
10.
Endo S, Yoshino Y, Shirota M, Watanabe G, Chiba N
Cancer Res Commun
. 2023 Mar;
1(2):90-105.
PMID: 36860287
Significance: ASHRA could evaluate HR activity in cells and predict the sensitivity to PARP inhibitors. High expression level of ATF1 may predict the resistance of BRCAness tumors with alterations of...